2008•Xinjiang Yike Daxue xuebaoRequires access

Expression and clinical significance of COX-2,Survivin in breast benign lesion and breast carcinoma

Jingying Li

Open publisher page 0 citations

Abstract

Objective:To investigate the relationship between the expression of cyclooxygenase-2(COX-2) and survivin in breast benign lesion,ductal carcinoma in situ and invasive breast carcinoma and their clinical significances.Methods:Sixty cases of breast benign lesion,60 cases of ductal carcinoma in situ and 60 cases of in invasive breast carcinoma were detected by of the immunohistochemical staining.Results:The positive rate of COX-2 were 50.00%(30/60) in breast benign lesion,76.67%(46/60) in breast ductal carcinoma in situ and 81.67%(49/60) in breast invasive ductal carcinoma,the difference showed statistically significance(P0.05).In breast benign lesion the positive rate of survivin was 41.67%(25/60),in breast ductal carcinoma in situ it was 60.00%(36/60),in breast invasive ductal carcinoma the positive rate of survivin was 70.00%(42/60),which were significantly different(P0.05).COX-2 expression was not associated with patient's age,tumor size,PR state,menopause or not(P0.05),but it was correlated with patient's lymph node metastasis,clinical stages,estrogen receptor positive(P0.05).Survivin expression was not associated with patient's age,tumor size,ER state,PR state,menopause or not(P0.05),but it was correlated with patient's lymphnode metastasis,clinical stages(P0.05).COX-2 expression was positive relation to survivin expression(r=0.33,P0.05).Conclusion:COX-2 and survivin might play an important role in the carcinogenesis and progression in breast carcinoma.A positive correlation between expression of COX-2 and survivin were observed in breast carcinoma,COX-2 has coordinated action with survivin in the carcinogenesis and progression in breast carcinoma.

About this research paper

What this paper is about

Objective:To investigate the relationship between the expression of cyclooxygenase-2(COX-2) and survivin in breast benign lesion,ductal carcinoma in situ and invasive breast carcinoma and their clinical significances.Methods:Sixty cases of breast benign lesion,60 cases of ductal carcinoma in situ and 60 cases of in invasive breast carcinoma were detected by of the immunohistochemical staining.Results:The positive rate of COX-2 were 50.00%(30/60) in breast benign lesion,76.67%(46/60) in breast ductal carcinoma in situ and 81.67%(49/60) in breast invasive ductal carcinoma,the difference showed statistically significance(P0.05).In breast benign lesion the positive rate of survivin was 41.67%(25/60),in breast ductal carcinoma in situ it was 60.00%(36/60),in breast invasive ductal carcinoma the positive rate of survivin was 70.00%(42/60),which were significantly different(P0.05).COX-2 expression was not associated with patient's age,tumor size,PR state,menopause or not(P0.05),but it was correlated with patient's lymph node metastasis,clinical stages,estrogen receptor positive(P0.05).Survivin expression was not associated with patient's age,tumor size,ER state,PR state,menopause or not(P0.05),but it was correlated with patient's lymphnode metastasis,clinical stages(P0.05).COX-2 expression was positive relation to survivin expression(r=0.33,P0.05).Conclusion:COX-2 and survivin might play an important role in the carcinogenesis and progression in breast carcinoma.A positive correlation between expression of COX-2 and survivin were observed in breast carcinoma,COX-2 has coordinated action with survivin in the carcinogenesis and progression in breast carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the relationship between the expression of cyclooxygenase-2(COX-2) and survivin in breast benign lesion,ductal carcinoma in situ and invasive breast carcinoma and their clinical significances.Methods:Sixty cases of breast benign lesion,60 cases of ductal carcinoma in situ and 60 cases of in invasive breast carcinoma were detected by of the immunohistochemical staining.Results:The positive rate of COX-2 were 50.00%(30/60) in breast benign lesion,76.67%(46/60) in breast ductal carcinoma in situ and 81.67%(49/60) in breast invasive ductal carcinoma,the difference showed statistically significance(P0.05).In breast benign lesion the positive rate of survivin was 41.67%(25/60),in breast ductal carcinoma in situ it was 60.00%(36/60),in breast invasive ductal carcinoma the positive rate of survivin was 70.00%(42/60),which were significantly different(P0.05).COX-2 expression was not associated with patient's age,tumor size,PR state,menopause or not(P0.05),but it was correlated with patient's lymph node metastasis,clinical stages,estrogen receptor positive(P0.05).Survivin expression was not associated with patient's age,tumor size,ER state,PR state,menopause or not(P0.05),but it was correlated with patient's lymphnode metastasis,clinical stages(P0.05).COX-2 expression was positive relation to survivin expression(r=0.33,P0.05).Conclusion:COX-2 and survivin might play an important role in the carcinogenesis and progression in breast carcinoma.A positive correlation between expression of COX-2 and survivin were observed in breast carcinoma,COX-2 has coordinated action with survivin in the carcinogenesis and progression in breast carcinoma.

Key concepts: Medicine, Survivin, Immunohistochemistry, Ductal carcinoma, Breast carcinoma, Clinical significance, Pathology, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and clinical significance of COX-2,Survivin in breast benign lesion and breast carcinoma — Research Paper | ScholarLens